Role of cardiovascular implantable electronic devices in delivering individualized disease-guided management of patients with non-valvular atrial fibrillation and high bleeding risk.
Daniel A N MascarenhasMunish SharmaPaul D ZieglerBharat K KanthariaPublished in: Acta cardiologica (2018)
In NVAF patients, AF burden assessment by CIEDs allows an individualised disease-guided approach to safe withdrawal of long-term OAC in patients with high bleeding risk who do not wish to continue long-term anticoagulation.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- left atrial
- catheter ablation
- left atrial appendage
- end stage renal disease
- direct oral anticoagulants
- heart failure
- ejection fraction
- chronic kidney disease
- newly diagnosed
- percutaneous coronary intervention
- prognostic factors
- risk factors
- aortic valve
- coronary artery disease
- patient reported outcomes
- patient reported